Author Question: The majority of dysphoric reactions (bad trips) to LSD generally a. dissipate within several ... (Read 28 times)

bobbie

  • Hero Member
  • *****
  • Posts: 592
The majority of dysphoric reactions (bad trips) to LSD generally
 
  a. dissipate within several hours after LSD administration
  b. last several days
  c. last several weeks
  d. last for years

Question 2

Studies of chronic users of cannabinoids have demonstrated that
 
  a. their general intellectual functions are substantially lower than those of nonusers (when groups are matched according to factors other than cannabis use)
  b. flashbacks may occur, but it is not clear that these are due to cannabis use but due to other drug use
  c. their body weights are significantly lower than in nonusers
  d. all of the above



dpost18

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library